Cumberland Pharmaceuticals Inc — Quarterly Financial Statistics (NASDAQ:CPIX) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics

Quarterly Annual

Cash from operating activities 1.9 M3.9 M843.8 K187.18 K3 024 4.93 M Cash from investing activities -26.81 K-1.23 M285.86 K-690.84 K-3.07 M -4.71 M Cash from financing activities -1.38 M-5.53 M-150.8 K-386.88 K-681.74 K -6.75 M Free cash flow 1.88 M3.83 M803.4 K154.94 K-40.82 K 4.75 M

Haberler

Cumberland Q4 Loss Narrows Y/Y as Talicia Launch Boosts Sales

Cumberland Pharmaceuticals Inc. (CPIX) Q4 2025 Earnings Call Prepared Remarks Transcript

Cumberland Pharmaceuticals hisseleri DMD ilacına FDA’nın hızlı izin vermesiyle yükseldi

Cumberland Pharmaceuticals shares rise on FDA fast track status for DMD drug

FDA fast tracks Cumberland’s DMD heart disease therapy

Niche Focus & Regulation Shape the Future of Healthcare Firms

Top Research Reports for NVIDIA, Netflix & Merck

Zacks Initiates Coverage of CPIX With Outperform Recommendation

Cumberland, RedHill’in Talicia işinde %30 pay için 4 milyon dolar yatırım yaptı

Cumberland invests $4 million for 30% stake in RedHill’s Talicia business

Cumberland’s injectable ibuprofen receives approval in Mexico

Jones James, Cumberland Pharmaceuticals (CPIX) hisselerinden 861 dolar değerinde satın aldı